Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-003577
Filing Date
2025-08-14
Accepted
2025-08-14 06:59:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8731
2 JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13D-1(K) p25-1614exhibit991.htm EX-99.1 4172
  Complete submission text file 0000902664-25-003577.txt   14814
Mailing Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP 1-339-970-7000
uniQure N.V. (Subject) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88012 | Film No.: 251214209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G